Keyword search (4,163 papers available)

"Montero-Odasso M" Authored Publications:

Title Authors PubMed ID
1 The effect of hearing ability on dual-task performance following multi-domain training in older adults with mild cognitive impairment: findings from the SYNERGIC trial Downey RI; Petersen BJ; Mohanathas N; Campos JL; Montero-Odasso M; Bherer L; Pichora-Fuller MK; Bray NW; Burhan AM; Camicioli R; Fraser S; Liu-Ambrose T; Lussier M; Middleton LE; Pieruccini-Faria F; Phillips NA; Li KZH; 41694460
SOH
2 Dementia Care Research and Psychosocial Factors Mancor E; Montero-Odasso M; Bherer L; Almeida QJ; Liu-Ambrose T; Middleton LE; Camicioli R; Li K; 41448628
CONCORDIA
3 Clinical Manifestations Gagnon C; Montero-Odasso M; Zou G; Speechley MR; Almeida QJ; Liu-Ambrose T; Middleton LE; Camicioli R; Bray NW; Li K; Fraser S; Pieruccini-Faria F; Burhan AM; Berryman N; Lussier M; Son S; Shoemaker JK; Bherer L; 41447475
CONCORDIA
4 Public Health Pieruccini-Faria F; Son S; Liu-Ambrose T; Burhan AM; Almeida QJ; Middleton LE; Li K; Fraser S; Bherer L; Montero-Odasso M; 41435121
CONCORDIA
5 Public Health Gurve D; Centen AP; Slack PJ; Dang-Vu TT; Belleville S; Anderson ND; Montero-Odasso M; Nygaard HB; Chertkow H; Feldman HH; Brewster PWH; Lim A; 41434309
PERFORM
6 Synergistic effects of exercise, cognitive training and vitamin D on gait performance and falls in mild cognitive impairment-secondary outcomes from the SYNERGIC trial Pieruccini-Faria F; Son S; Zou G; Almeida QJ; Middleton LE; Bray NW; Lussier M; Shoemaker JK; Speechley M; Liu-Ambrose T; Burhan AM; Camicioli R; Li KZH; Fraser S; Berryman N; Bherer L; Montero-Odasso M; 40966614
SOH
7 Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Collins DL; Dadar M; DeMarco ML; Ducharme S; Duchesne S; Einstein G; Fisk JD; Gawryluk JR; Grossman L; Ismail Z; Itzhak I; Joshi M; Harrison A; Kroger E; Kumar S; Laforce R; Lanctot KL; Lau M; Lee L; Masellis M; Massoud F; Mitchell SB; Montero-Odasso M; Myers Barnett K; Nygaard HB; Pasternak SH; Peters J; Rajah MN; Robillard JM; Rockwood K; Rosa-Neto P; Seitz DP; Soucy JP; Trenaman SC; Wellington CL; Zadem A; Chertkow H; 39893139
CONCORDIA
8 Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA) Chertkow H; Phillips N; Rockwood K; Anderson N; Andrew MK; Bartha R; Beaudoin C; Bélanger N; Bellec P; Belleville S; Bergman H; Best S; Bethell J; Bherer L; Black S; Borrie M; Camicioli R; Carrier J; Cashman N; Chan S; Crowshoe L; Cuello C; Cynader M; Dang-Vu T; Das S; Dixon RA; Ducharme S; Einstein G; Evans AC; Fahnestock M; Feldman H; Ferland G; Finger E; Fisk JD; Fogarty J; Fon E; Gan-Or Z; Gauthier S; Greenwood C; Henri-Bellemare C; Herrmann N; Hogan DB; Hsiung R; Itzhak I; Jacklin K; Lanctôt K; Lim A; MacKenzie I; Masellis M; Maxwell C; McAiney C; McGilton K; McLaurin J; Mihailidis A; Mohades Z; Montero-Odasso M; Morgan D; Naglie G; Nygaard H; O' Connell M; Petersen R; Pilon R; Rajah MN; Rapoport M; Roach P; Robillard JM; Rogaeva E; Rosa-Neto P; Rylett J; Sadavoy J; St George-Hyslop P; Seitz D; Smith E; Stefanovic B; Vedel I; Walker JD; Wellington C; Whitehead V; Wittich W; 39636028
HKAP
9 Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study Caballero HS; McFall GP; Gee M; MacDonald S; Phillips NA; Fogarty J; Montero-Odasso M; Camicioli R; Dixon RA; 38875040
PSYCHOLOGY
10 Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment: A Randomized Clinical Trial Montero-Odasso M; Zou G; Speechley M; Almeida QJ; Liu-Ambrose T; Middleton LE; Camicioli R; Bray NW; Li KZH; Fraser S; Pieruccini-Faria F; Berryman N; Lussier M; Shoemaker JK; Son S; Bherer L; 37471089
PERFORM
11 Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab Chertkow H; Rockwood K; Hogan DB; Phillips N; Montero-Odasso M; Amanullah S; Black S; Bocti C; Borrie M; Feldman H; Freedman M; Hsiung R; Kirk A; Masellis M; Nygaard H; Rajji T; Verret L; 34912492
PSYCHOLOGY
12 Comparing the effect of Cognitive vs. Exercise Training on brain MRI outcomes in healthy older adults: A systematic review Intzandt B; Vrinceanu T; Huck J; Vincent T; Montero-Odasso M; Gauthier CJ; Bherer L; 34245760
PERFORM
13 Gait variability across neurodegenerative and cognitive disorders: Results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study. Pieruccini-Faria F, Black SE, Masellis M, Smith EE, Almeida QJ, Li KZH, Bherer L, Camicioli R, Montero-Odasso M 33590967
PSYCHOLOGY
14 CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus Montero-Odasso M; Pieruccini-Faria F; Ismail Z; Li K; Lim A; Phillips N; Kamkar N; Sarquis-Adamson Y; Speechley M; Theou O; Verghese J; Wallace L; Camicioli R; 33094146
CRDH
15 Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Ismail Z, Black SE, Camicioli R, Chertkow H, Herrmann N, Laforce R, Montero-Odasso M, Rockwood K, Rosa-Neto P, Seitz D, Sivananthan S, Smith EE, Soucy JP, Vedel I, Gauthier S, CCCDTD5 participants 32725777
PERFORM
16 Guidelines for Gait Assessments in the Canadian Consortium on Neurodegeneration in Aging (CCNA). Cullen S, Montero-Odasso M, Bherer L, Almeida Q, Fraser S, Muir-Hunter S, Li K, Liu-Ambrose T, McGibbon CA, McIlroy W, Middleton LE, Sarquis-Adamson Y, Beauchet O, McFadyen BJ, Morais JA, Camicioli R, Canadian Gait and Cognition Network 29977431
ENCS
17 SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment. Montero-Odasso M, Almeida QJ, Burhan AM, Camicioli R, Doyon J, Fraser S, Li K, Liu-Ambrose T, Middleton L, Muir-Hunter S, McIlroy W, Morais JA, Pieruccini-Faria F, Shoemaker K, Speechley M, Vasudev A, Zou GY, Berryman N, Lussier M, Vanderhaeghe L, Bherer L 29661156
PERFORM
18 Consensus on Shared Measures of Mobility and Cognition: From the Canadian Consortium on Neurodegeneration in Aging (CCNA). Montero-Odasso M, Almeida QJ, Bherer L, Burhan AM, Camicioli R, Doyon J, Fraser S, Muir-Hunter S, Li KZH, Liu-Ambrose T, McIlroy W, Middleton L, Morais JA, Sakurai R, Speechley M, Vasudev A, Beauchet O, Hausdorff JM, Rosano C, Studenski S, Verghese J, Canadian Gait and Cognition Network 30101279
PERFORM

 

Title:Clinical Manifestations
Authors:Gagnon CMontero-Odasso MZou GSpeechley MRAlmeida QJLiu-Ambrose TMiddleton LECamicioli RBray NWLi KFraser SPieruccini-Faria FBurhan AMBerryman NLussier MSon SShoemaker JKBherer L
Link:https://pubmed.ncbi.nlm.nih.gov/41447475/
DOI:10.1002/alz70857_102937
Publication:Alzheimer s & dementia : the journal of the Alzheimer s Association
Keywords:
PMID:41447475 Category: Date Added:2025-12-25
Dept Affiliation: CONCORDIA
1 Montreal Heart Institute, Montreal, QC, Canada.
2 Schulich School of Medicine & Dentistry, Division of Geriatric Medicine, Western University, London, ON, Canada.
3 Parkwood Institute, London, ON, Canada.
4 Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
5 University of Wester Ontario, London, ON, Canada.
6 Wilfrid Laurier University, Waterloo, ON, Canada.
7 Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
8 Centre for Aging SMART, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
9 University of British Columbia, Vancouver, BC, Canada.
10 Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada.
11 Schlegel-UW Research Institute for Aging, Waterloo, ON, Canada.
12 University of Waterloo, Waterloo, ON, Canada.
13 University of Alberta, Edmonton, AB, Canada.
14 University of Western Ontario, London, ON, Canada.
15 Concordia University, Montreal, QC, Canada.
16 University of Ottawa, Ottawa, ON, Canada.
17 Gait and Brain Laboratory, Parkwood Institute, London, ON, Canada.
18 Gait & Brain Lab; Lawson Research Institute; Schulich School of Medicine& Dentistry, Division of Geriatric Medicine, Western University, London, ON, Canada.
19 University of Toronto, Toronto, ON, Canada.
20 Parkwood Institute-Mental Health, Western University, London, ON, Canada.
21 Western University, London, ON, Canada.
22 Ontario Shores Centre for Mental Health Sciences, Whitby, ON, Canada.
23 Université du Québec à Montréal, Montréal, QC, Canada.
24 University of Montreal, Montreal, QC, Canada.
25 Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), Montreal, QC, Canada.
26 Université de Montréal, Montréal, QC, Canada.
27 Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada.
28 Montreal Heart Institute, Montréal, QC, Canada.

Description:

Background: In recent years, many studies have investigated the effects of non-pharmacological interventions (e.g. physical and cognitive training) on cognition in patients with mild cognitive impairment. The SYNERGIC trial showed that combining physical exercise and cognitive training leads to greater gains on the ADAS-Cog than an active control condition, and physical exercise alone. Yet not all participants showed the same cognitive gains. To date, little is known about the cognitive characteristics of responders vs non-responders to non-pharmacological interventions.

Objective: To compare baseline cognitive profiles of responders and non-responders to physical exercise training alone or in combination with cognitive training.

Methods: Of the 175 initially randomized individuals with MCI in the SYNERGIC trial, 143 completed the 6-month assessment. Regardless of randomization, participants were identified as responders if the change in ADAS-Cog-13 (T6-T0) was negative, indicating improved performances, and non-responders were determined if change was null or positive, indicating decreased performance. Composite z-scores were calculated from the baseline neuropsychological assessment: Global cognition (MoCA), Language (Boston Naming Test, Semantic Verbal fluency), Memory (MoCA delayed recall subscore), Processing Speed (TMT A, Stroop Naming, Stroop Reading), Working Memory (Digit span forward and backward), and Executive Functions (TMT B, Stroop Inhibition and Switching).

Results: Responders (n = 91; 72yrs, 46% female, ADAS-Cog(T0): 15.81) and non-responders (n = 52; 74.2yrs, 54% female, ADAS-Cog(T0): 15.13) were comparable for sex, baseline ADAS-Cog; a trend was observed for older age in non-responders (p = .062). Overall, at baseline, responders had better global cognition (0.14±0.94 vs -0.23±1.07) and executive function performances than non-responders (0.12±0.77 vs-0.21±0.97), ps < .05, but were otherwise comparable. In the intervention arms, the proportion of responders differed significantly: Combined (75%), Physical alone (61%), Active control (44%), (p < .05). In the Combined group, responders had better global cognition (0.38±0.96 Vs -0.20±0.97) and working memory performances (0.25±0.96 Vs -0.28±0.47). In the Physical Alone group, responders and non-responders performed similarly. In the Active Control group, responders had better processing speed performances (0.22±0.31 vs -0.33±0.79) than non-responders.

Conclusion: Responders and non-responders appear to have different baseline cognitive profiles. These results suggest that cognitive and physical training interventions should be tailored and individualized according to baseline cognitive condition.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University